Overview As Director, Global Early Asset & Business Development you translate early signals into strategic investment decisions across pre-clinical to Phase 3 and in-licensing. You'll lead forecast development, patient-based models, and commercial diligence, partnering with cross-functional teams to inform gates and portfolio choices. This role combines science, finance, and strategy to impact patient access and outcomes.

Compensaciones / Beneficios in-person work 3 days per week versátil work arrangements global network and development opportunities Lead early forecasting across epidemiology, adoption, and policy shifts to guide stage-gate decisions and allocation of resources Build patient-based forecast models integrating primary/secondary data and analog benchmarks for investment cases Deliver commercial diligence and market models for in-licensing, partnerships, and acquisitions with clear risk-adjusted recommendations Advise senior leaders on forecast drivers, model changes,



and implications for pipeline and deal strategy Design and oversee vendor-led qualitative and quantitative market research to guide investments and strategy Identify and embed AI, automation, and advanced analytics to improve insight speed, quality, and explainability Requisitos principales Bachelor's degree required; advanced degree preferred (MBA, MS, or PhD in a quantitative, scientific, or life-sciences discipline) 6+ years of relevant pharma, biotech, or consulting experience in forecasting, early-stage pipeline strategy, or market insights Proficiency with NPV, risk-adjusted forecasting, scenarios, and sensitivity analyses for investment cases Understanding of key commercial drivers, market access, pricing, reimbursement, and US/general policy factors Clear, concise communication of complex data to senior stakeholders and governance bodies Ability to build trust and alignment across global and US stakeholders Executive-level storytelling Scenario planning and sensitivity analysis

📌 Global Insights & Forecasting Director - Early Assets & Business Development, R&I (Barcelona)
🏢 AstraZeneca
📍 Barcelona